The Stafford Fox Rare Cancer Program (SFRCP)

GROUP Rare Cancers
PROJECT SPAN 2022
DATE 02/05/2022

The Stafford Fox Rare Cancer Program (SFRCP)

The Walter Eliza Hall Institute (WEHI) of Medical Research Stafford Fox Rare Cancer Program is a basic and translational research program for all rare cancers.

More information

It is based at the WEHI and is accessible through participating tertiary hospitals or via the ARC Portal. The SFRCP has internal research projects but can also help to facilitate external rare cancer research with access to clinically annotated rare cancer biospecimens.

Examples of projects supported by the SFRCP include:

Identification of novel drivers in patients with multiple rare cancers
Next generation sequencing of rare gynaecological malignancies
Understanding the distinct biology of gynaecological carcinosarcomas
Immunology and genomics of rare cancer super-responders
Novel therapies for high grade serous endometrial carcinomas
Uterine Leiomyosarcoma – genomics, pre-clinical models and therapeutics
Studies into ovarian sex-cord stromal tumours

wehi.edu.au/research-diseases/cancer/rare-cancers

Related projects

Rare Cancers

The Australian Genomic Cancer Medicine Centre (AGCMC) and Molecular Screening and Therapeutics (MoST)

Rare Cancers

The Australian Rare Cancer (ARC) Portal

Join Australia's leading oncology community & make an impact

Become a COSA member

Twitter
@COSAoncology

COSAoncology 14 hours ago

Thank you, @dietitiansaus for continuing your COSA Associated organisation membership! DA members are invited to join or renew with COSA at discounted rates: bit.ly/3s5mOC6

COSAoncology 18 hours ago

Did you know ANZHNCS members can join COSA at a discounted rate? Thank you to @anzhncs for continuing Affiliated organisation membership with COSA. bit.ly/3s5mOC6

COSAoncology yesterday

Cancer pharmacists will gather in Melbourne this weekend for the COSA CPG Clinical Practice Course. There are streams for those with a basic knowledge and those with an advanced clinical level in oncology and haematology pharmacy practice.

COSAoncology yesterday

Our April member newsletter is out now with Group updates, new resources, journal articles, oncology events and more. Check your inbox or view the COSA eNews online at bit.ly/42SWNrG

COSAoncology 2 days ago

Join or renew as a COSA member by 16 May 2025 to make a saving! For members, your renewal email is in your inbox today. bit.ly/3hXsDLm

COSAoncology 2 days ago

Cancer Nurses Society @CNSA_ORG, thank you for continuing your COSA Affiliated organisation membership. CNSA members are invited to save on COSA membership: bit.ly/3s5mOC6

COSAoncology 8 days ago

Thank you @BCTrialsANZ for continuing your Affiliated organisation membership with COSA. BCT members can join or renew with COSA at discounted rates: cosa.org.au/membership/mem…

COSAoncology 14 days ago

Thanks to the Australian Society of Medical Imaging and Radiation Therapy for renewing as a COSA Associated organisation. #ASMIRT members are invited to take advantage of discounted COSA membership: cosa.org.au/membership/mem…

COSAoncology 14 days ago

Thank you, @PathologyRCPA for continuing as a COSA Affiliated organisation. Did you know RCPA members can join or renew with COSA at a discounted rate? bit.ly/3s5mOC6

COSAoncology 15 days ago

The latest Cancer Pharmacists Group eNews in CPG members' inboxes and on the COSA website. Stay up to date and stay connected. bit.ly/3RhZY6Q